Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

This study tests a "hypofractionated" radiation therapy approach — delivering higher doses per session over fewer visits — for people with nasopharyngeal carcinoma (cancer at the back of the nasal cavity, behind the nose). The goal is to see if this schedule is as effective as traditional longer courses with fewer side effects. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with nasopharyngeal carcinoma confirmed by biopsy - You have at least one measurable tumor on imaging - You are in reasonably good health (performance status 0-2) - Your blood counts and organ function (liver, kidneys) are within acceptable levels - Your expected survival is 6 months or more **You may NOT be eligible if...** - Your blood counts or organ function do not meet required thresholds - You have another serious or unrelated medical condition - You are not healthy enough to tolerate radiation Talk to your doctor to see if this trial is right for you.